Shujuan Wen

机构：Xinjiang Medical University, Guangxi Medical University, Tumor Hospital of Xinjiang Medical University

发表论文 28 篇 · 总被引 195 次 · h-index 8

代表论文

• Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways (2018 · International Immunopharmacology · 被引 28)
• RETRACTED: Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation (2019 · Biomedicine & Pharmacotherapy · 被引 27)
• Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways (2021 · International Immunopharmacology · 被引 22)
• Downregulation of MANCR inhibits cancer cell proliferation in mantle cell lymphoma possibly by interacting with RUNX2 (2019 · Acta Biochimica et Biophysica Sinica · 被引 21)
• Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma (2017 · Medicine · 被引 18)
• Comprehensive analysis of transcriptomics and metabolomics to illustrate the underlying mechanism of helenalin against hepatic fibrosis (2022 · European Journal of Pharmacology · 被引 16)